Iguratimod ameliorates antibody-mediated rejection after renal transplant by modulating the Th17/Treg paradigm
Article in International Immunopharmacology (June 2024)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Iguratimod prevents renal fibrosis in unilateral ureteral obstruction model mice by suppressing M2 macrophage infiltration and macrophage–myofibroblast transition
Article in Renal Failure (April 2024)
Efficacy of iguratimod on mineral and bone disorders after kidney transplantation: a preliminary study
Article in Renal Failure (October 2023)